Aaron Berger

Head of Peri- & Post-Approval Services

Aaron Berger serves as the VP, Peri- & Post-Approval Services for UBC. In this role, he works towards the strategic design and execution of late stage clinical trials and observational research that will generate powerful, real world evidence of product effectiveness, safety, and value.

Aaron joined the UBC team in 2003 and has since served in a range of diverse roles leveraging global capabilities in the execution of peri- and post-marketing product development programs and real world evidence generation. He has supported the development of RWD / RWE architectures and solutions to drive greater insight into the safety profile and value proposition of medicines.

SCOPE 2023 – Bringing Focus onto the Patient

Blog | February 23, 2023

This year's SCOPE Summit focused on the hybridization of research facilitating better evidence generation through patient-centric study design & execution.